CAR T, immunotherapy bring new hope for multiple myeloma patients – Medical Xpress
Medical Xpress |
CAR T, immunotherapy bring new hope for multiple myeloma patients
Medical Xpress Two investigational immunotherapy approaches, including chimeric antigen receptor (CAR) T cell therapy, have shown encouraging results in the treatment of multiple myeloma patients who had relapsed and were resistant to other … 'Unheard of' responses to bluebird CAR–T therapy seen in myeloma study #ASH17: The BCMA-targeted CAR–T bb2121 from bluebird and Celgene takes a star turn in the spotlight CAR T, immunotherapy bring new hope for multiple myeloma patients |
